机译:Retraction and republication—Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial (The Lancet Oncology (2022) 23(3) (e105–e115), (S1470204522000663), (10.1016/S1470-2045(22)00066-3))